Multipel sklerose (Danish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Multipel sklerose" in Danish language version.

refsWebsite

Global rank Danish rank

86nih.gov

4^th place

24^th place

65doi.org

2^nd place

13^th place

10web.archive.org

1^st place

9archive.org

6^th place

12^th place

5clinicaltrials.gov

5,225^th place

low place

2springer-ny.com

low place

2msforumonline.net

low place

2neurology.org

9,919^th place

low place

2nejm.org

2,374^th place

1,805^th place

1ucl.ac.uk

1,306^th place

1,011^th place

1videnskab.dk

low place

38^th place

1archive.today

14^th place

37^th place

1asm.org

3,555^th place

2,247^th place

1neurologyreviews.com

low place

1abstracts2view.com

low place

1primetherapeutics.com

low place

1wsj.com

79^th place

259^th place

1sagepub.com

731^st place

1,641^st place

1mxga-mstrial.co.uk

low place

1genzyme.com

low place

1pdl.com

low place

1pnas.org

1,293^rd place

583^rd place

1bmj.com

1,226^th place

1,661^st place

1worldcat.org

5^th place

36^th place

1canadianhealthcarenetwork.ca

low place

1msrc.co.uk

low place

abstracts2view.com

Natalizumab reduces MS severity – http://www.abstracts2view.com/aan2008chicago/view.php?nu=AAN08L_P04.169 Arkiveret 7. juli 2011 hos Wayback Machine

archive.org

Ascherio A, Munger KL (april 2007). "Environmental risk factors for multiple sclerosis. Part I: the role of infection". Ann. Neurol. 61 (4): 288-99. doi:10.1002/ana.21117. PMID 17444504.
Lublin FD, Reingold SC (april 1996). "Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis". Neurology. 46 (4): 907-11. PMID 8780061.
Kurtzke JF (1983). "Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)". Neurology. 33 (11): 1444-52. PMID 6685237.
Ascherio A, Munger KL (juni 2007). "Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors". Ann. Neurol. 61 (6): 504-13. doi:10.1002/ana.21141. PMID 17492755.
McDonald WI, Compston A, Edan G; et al. (juli 2001). "Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis". Ann. Neurol. 50 (1): 121-7. doi:10.1002/ana.1032. PMID 11456302. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Polman CH, Reingold SC, Edan G; et al. (december 2005). "Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"". Ann. Neurol. 58 (6): 840-6. doi:10.1002/ana.20703. PMID 16283615. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Brusaferri F, Candelise L (2000). "Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials". J. Neurol. 247 (6): 435-42. doi:10.1007/s004150070172. PMID 10929272.
Comi G, Filippi M, Barkhof F; et al. (2001). "Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study". Lancet. 357 (9268): 1576-82. doi:10.1016/s0140-6736(00)04725-5. PMID 11377645. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Barbellion, Wilhelm Nero Pilate (1919). The Journal of a Disappointed Man. New York: George H. Doran.

archive.today

Kurtzke JF (oktober 1993). "Epidemiologic evidence for multiple sclerosis as an infection". Clin. Microbiol. Rev. 6 (4): 382-427. PMC 358295. PMID 8269393. Arkiveret fra originalen 5. december 2012. Hentet 6. februar 2010.

asm.org

cmr.asm.org

Kurtzke JF (oktober 1993). "Epidemiologic evidence for multiple sclerosis as an infection". Clin. Microbiol. Rev. 6 (4): 382-427. PMC 358295. PMID 8269393. Arkiveret fra originalen 5. december 2012. Hentet 6. februar 2010.

bmj.com

jnnp.bmj.com

Zamboni, P; Galeotti, R; Menegatti, E; Malagoni, AM; Tacconi, G; Dall’Ara, S; Bartolomei, I; Salvi, F (2009). "Chronic Cerebrospinal venous insufficiency in patients with multiple sclerosis". Journal of Neurology, Neurosurgery and Psychiatry. BMJ Publishing Group. 80 (4): 392-399. doi:10.1136/jnnp.2008.157164. ISSN 1468-330X. Hentet 21. december 2009.

canadianhealthcarenetwork.ca

"Angioplasty for MS? Italian surgeon's claims prompt media circus, but Canadian doctors are skeptical". Medical Post. Hentet 16. december 2009.{{cite web}}: CS1-vedligeholdelse: url-status (link)

clinicaltrials.gov

"Treatment of Multiple Sclerosis Using Over the Counter Inosine". ClinicalTrials.gov. 2006-03-16. Hentet 2007-09-02.
"Efficacy and Safety of BG00012 in Relapsing-Remitting Multiple Sclerosis". ClinicalTrials.gov. 2007-09-01. Hentet 2007-11-12.
"Efficacy and Safety of Fingolimod in Patients With Relapsing-Remitting Multiple Sclerosis". ClinicalTrials.gov. 2006-02-10. Hentet 2007-09-02.
search of clinicaltrials.gov data-base for Low dose naltrexone Multiple Sclerosis
2007 clinical trial using LDN

doi.org

Compston A, Coles A (oktober 2008). "Multiple sclerosis". Lancet. 372 (9648): 1502-17. doi:10.1016/S0140-6736(08)61620-7. PMID 18970977.
Rosati G (april 2001). "The prevalence of multiple sclerosis in the world: an update". Neurol. Sci. 22 (2): 117-39. doi:10.1007/s100720170011. PMID 11603614.
Compston A, Coles A (april 2002). "Multiple sclerosis". Lancet. 359 (9313): 1221-31. doi:10.1016/S0140-6736(02)08220-X. PMID 11955556.
Ascherio A, Munger KL (april 2007). "Environmental risk factors for multiple sclerosis. Part I: the role of infection". Ann. Neurol. 61 (4): 288-99. doi:10.1002/ana.21117. PMID 17444504.
Weinshenker BG (1994). "Natural history of multiple sclerosis". Ann. Neurol. 36 (Suppl): S6-11. doi:10.1002/ana.410360704. PMID 8017890.
Petzold, Axel; Fraser, Clare L.; Abegg, Mathias (2022). "Diagnosis and classification of optic neuritis". The Lancet Neurology (engelsk). 21 (12). doi:10.1016/S1474-4422(22)00200-9. PMID 36179757.
Tataru N, Vidal C, Decavel P, Berger E, Rumbach L (2006). "Limited impact of the summer heat wave in France (2003) on hospital admissions and relapses for multiple sclerosis". Neuroepidemiology. 27 (1): 28-32. doi:10.1159/000094233. PMID 16804331.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Heesen C, Mohr DC, Huitinga I; et al. (marts 2007). "Stress regulation in multiple sclerosis: current issues and concepts". Mult. Scler. 13 (2): 143-8. doi:10.1177/1352458506070772. PMID 17439878. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Martinelli V (2000). "Trauma, stress and multiple sclerosis". Neurol. Sci. 21 (4 Suppl 2): S849-52. doi:10.1007/s100720070024. PMID 11205361. Arkiveret fra originalen 1. november 2013. Hentet 6. februar 2010.
Dyment DA, Ebers GC, Sadovnick AD (februar 2004). "Genetics of multiple sclerosis". Lancet Neurol. 3 (92): 104-10. doi:10.1016/S1474-4422(03)00663-X. PMID 14747002.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Marrie RA (december 2004). "Environmental risk factors in multiple sclerosis aetiology". Lancet Neurol. 3 (12): 709-18. doi:10.1016/S1474-4422(04)00933-0. PMID 15556803.
Ascherio A, Munger KL (juni 2007). "Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors". Ann. Neurol. 61 (6): 504-13. doi:10.1002/ana.21141. PMID 17492755.
Spitsin S, Koprowski H (2008). "Role of uric acid in multiple sclerosis". Curr. Top. Microbiol. Immunol. 318: 325-42. doi:10.1007/978-3-540-73677-6_13. PMID 18219824.
Johnston JB, Silva C, Holden J, Warren KG, Clark AW, Power C (oktober 2001). "Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases". Ann. Neurol. 50 (4): 434-42. doi:10.1002/ana.1131. PMID 11601494.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Chari DM (2007). "Remyelination in multiple sclerosis". Int. Rev. Neurobiol. 79: 589-620. doi:10.1016/S0074-7742(07)79026-8. PMID 17531860.
Pittock SJ, Lucchinetti CF (marts 2007). "The pathology of MS: new insights and potential clinical applications". Neurologist. 13 (2): 45-56. doi:10.1097/01.nrl.0000253065.31662.37. PMID 17351524.
Ho PP, Kanter JL, Johnson AM; et al. (juni 2012). "Identification of naturally occurring fatty acids of the myelin sheath that resolve neuroinflammation". Sci Transl Med. 4 (137): 137ra73. doi:10.1126/scitranslmed.3003831. PMID 22674551. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Iglesias A, Bauer J, Litzenburger T, Schubart A, Linington C (november 2001). "T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis". Glia. 36 (2): 220-34. doi:10.1002/glia.1111. PMID 11596130.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Trojano M, Paolicelli D (november 2001). "The differential diagnosis of multiple sclerosis: classification and clinical features of relapsing and progressive neurological syndromes". Neurol. Sci. 22 (Suppl 2): s.98-102. doi:10.1007/s100720100044. PMID 11794488.
Poser CM, Brinar VV (juni 2004). "Diagnostic criteria for multiple sclerosis: an historical review". Clin Neurol Neurosurg. 106 (3): 147-58. doi:10.1016/j.clineuro.2004.02.004. PMID 15177763.
McDonald WI, Compston A, Edan G; et al. (juli 2001). "Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis". Ann. Neurol. 50 (1): 121-7. doi:10.1002/ana.1032. PMID 11456302. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Polman CH, Reingold SC, Edan G; et al. (december 2005). "Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"". Ann. Neurol. 58 (6): 840-6. doi:10.1002/ana.20703. PMID 16283615. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Rashid W, Miller DH (februar 2008). "Recent advances in neuroimaging of multiple sclerosis". Semin Neurol. 28 (1): 46-55. doi:10.1055/s-2007-1019127. PMID 18256986.
Link H, Huang YM (november 2006). "Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness". J. Neuroimmunol. 180 (1-2): 17-28. doi:10.1016/j.jneuroim.2006.07.006. PMID 16945427.
Pittock SJ, Rodriguez M (2008). "Benign multiple sclerosis: a distinct clinical entity with therapeutic implications". Curr. Top. Microbiol. Immunol. 318: 1-17. doi:10.1007/978-3-540-73677-6_1. PMID 18219812.
Miller D, Barkhof F, Montalban X, Thompson A, Filippi M (maj 2005). "Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis". Lancet Neurol. 4 (5): 281-8. doi:10.1016/S1474-4422(05)70071-5. PMID 15847841.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Rovaris M, Confavreux C, Furlan R, Kappos L, Comi G, Filippi M (april 2006). "Secondary progressive multiple sclerosis: current knowledge and future challenges". Lancet Neurol. 5 (4): 343-54. doi:10.1016/S1474-4422(06)70410-0. PMID 16545751.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Miller DH, Leary SM (oktober 2007). "Primary-progressive multiple sclerosis". Lancet Neurol. 6 (10): 903-12. doi:10.1016/S1474-4422(07)70243-0. PMID 17884680.
Brusaferri F, Candelise L (2000). "Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials". J. Neurol. 247 (6): 435-42. doi:10.1007/s004150070172. PMID 10929272.
Dovio A, Perazzolo L, Osella G; et al. (2004). "Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis". J. Clin. Endocrinol. Metab. 89 (10): 4923-8. doi:10.1210/jc.2004-0164. PMID 15472186. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Uttner I, Müller S, Zinser C; et al. (2005). "Reversible impaired memory induced by pulsed methylprednisolone in patients with MS". Neurology. 64 (11): 1971-3. doi:10.1212/01.WNL.0000163804.94163.91. PMID 15955958. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Jacobs LD, Beck RW, Simon JH; et al. (2000). "Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group". N Engl J Med. 343 (13): 898-904. doi:10.1056/NEJM200009283431301. PMID 11006365. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Comi G, Filippi M, Barkhof F; et al. (2001). "Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study". Lancet. 357 (9268): 1576-82. doi:10.1016/s0140-6736(00)04725-5. PMID 11377645. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Kappos L, Freedman MS, Polman CH; et al. (2007). "Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study". Lancet. 370 (9585): 389-97. doi:10.1016/S0140-6736(07)61194-5. PMID 17679016. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Ruggieri M, Avolio C, Livrea P, Trojano M (2007). "Glatiramer acetate in multiple sclerosis: a review". CNS Drug Rev. 13 (2): 178-91. doi:10.1111/j.1527-3458.2007.00010.x. PMID 17627671.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Munari L, Lovati R, Boiko A (2004). "Therapy with glatiramer acetate for multiple sclerosis". Cochrane Database Syst Rev (1): CD004678. doi:10.1002/14651858.CD004678. PMID 14974077.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Rice GP, Incorvaia B, Munari L; et al. (2001). "Interferon in relapsing-remitting multiple sclerosis". Cochrane Database Syst Rev (4): CD002002. doi:10.1002/14651858.CD002002. PMID 11687131. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Martinelli Boneschi F, Rovaris M, Capra R, Comi G (2005). "Mitoxantrone for multiple sclerosis". Cochrane Database Syst Rev (4): CD002127. doi:10.1002/14651858.CD002127.pub2. PMID 16235298.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Johnson KP (2007). "Control of multiple sclerosis relapses with immunomodulating agents". J. Neurol. Sci. 256 (Suppl 1): S23-8. doi:10.1016/j.jns.2007.01.060. PMID 17350652.
Gonsette RE (2007). "Compared benefit of approved and experimental immunosuppressive therapeutic approaches in multiple sclerosis". Expert opinion on pharmacotherapy. 8 (8): 1103-16. doi:10.1517/14656566.8.8.1103. PMID 17516874.
Murray TJ (2006). "The cardiac effects of mitoxantrone: do the benefits in multiple sclerosis outweigh the risks?". Expert opinion on drug safety. 5 (2): 265-74. doi:10.1517/14740338.5.2.265. PMID 16503747.
Leary SM, Thompson AJ (2005). "Primary progressive multiple sclerosis: current and future treatment options". CNS drugs. 19 (5): 369-76. doi:10.2165/00023210-200519050-00001. PMID 15907149.
Fox EJ (2006). "Management of worsening multiple sclerosis with mitoxantrone: a review". Clinical therapeutics. 28 (4): 461-74. doi:10.1016/j.clinthera.2006.04.013. PMID 16750460.
Kleinschmidt-DeMasters BK, Tyler KL (2005). "Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis". N Engl J Med. 353 (4): 369-74. doi:10.1056/NEJMoa051782. PMID 15947079. Arkiveret fra originalen 1. december 2009. Hentet 6. februar 2010.
Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D (2005). "Progressive multifocal leukoencephalopathy in a patient treated with natalizumab". N Engl J Med. 353 (4): 375-81. doi:10.1056/NEJMoa051847. PMID 15947078. Arkiveret fra originalen 1. december 2009. Hentet 6. februar 2010.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Farinotti M, Simi S, Di Pietrantonj C; et al. (2007). "Dietary interventions for multiple sclerosis". Cochrane database of systematic reviews (Online) (1): CD004192. doi:10.1002/14651858.CD004192.pub2. PMID 17253500. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Chong MS, Wolff K, Wise K, Tanton C, Winstock A, Silber E (2006). "Cannabis use in patients with multiple sclerosis". Mult. Scler. 12 (5): 646-51. doi:10.1177/1352458506070947. PMID 17086912.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Zajicek JP, Sanders HP, Wright DE, Vickery PJ, Ingram WM, Reilly SM, Nunn AJ, Teare LJ, Fox PJ, Thompson AJ (2005). "Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up". J. Neurol. Neurosurg. Psychiatr. 76 (12): 1664-9. doi:10.1136/jnnp.2005.070136. PMC 1739436. PMID 16291891.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Bennett M, Heard R (2004). "Hyperbaric oxygen therapy for multiple sclerosis". Cochrane database of systematic reviews (Online) (1): CD003057. doi:10.1002/14651858.CD003057.pub2. PMID 14974004.
Phadke JG (maj 1987). "Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland". J. Neurol. Neurosurg. Psychiatr. 50 (5): 523-31. doi:10.1136/jnnp.50.5.523. PMC 1031962. PMID 3495637.
Alonso A, Hernán MA (juli 2008). "Temporal trends in the incidence of multiple sclerosis: a systematic review". Neurology. 71 (2): 129-35. doi:10.1212/01.wnl.0000316802.35974.34. PMID 18606967.
Kulie T, Groff A, Redmer J, Hounshell J, Schrager S (2009). "Vitamin D: an evidence-based review". J Am Board Fam Med. 22 (6): 698-706. doi:10.3122/jabfm.2009.06.090037. PMID 19897699.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Compston A (oktober 1988). "The 150th anniversary of the first depiction of the lesions of multiple sclerosis". J. Neurol. Neurosurg. Psychiatr. 51 (10): 1249-52. doi:10.1136/jnnp.51.10.1249. PMC 1032909. PMID 3066846.
Medaer R (september 1979). "Does the history of multiple sclerosis go back as far as the 14th century?". Acta Neurol. Scand. 60 (3): 189-92. doi:10.1111/j.1600-0447.1979.tb08970.x. PMID 390966.
Holmøy T (2006). "A Norse contribution to the history of neurological diseases". Eur. Neurol. 55 (1): 57-8. doi:10.1159/000091431. PMID 16479124.
Pearce JM (2005). "Historical descriptions of multiple sclerosis". Eur. Neurol. 54 (1): 49-53. doi:10.1159/000087387. PMID 16103678.
The CAMMS223 Trial Investigators (2008). "Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis". N Engl J Med. 359 (17): 1786-1801. doi:10.1056/NEJMoa0802670. PMID 18946064.
Polman C, Barkhof F, Sandberg-Wollheim M, Linde A, Nordle O, Nederman T (2005). "Treatment with laquinimod reduces development of active MRI lesions in relapsing MS". Neurology. 64 (6): 987-91. doi:10.1212/01.WNL.0000154520.48391.69. PMID 15781813.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Agrawal YP (2005). "Low dose naltrexone therapy in multiple sclerosis". Med. Hypotheses. 64 (4): 721-4. doi:10.1016/j.mehy.2004.09.024. PMID 15694688.
Gironi M, Martinelli-Boneschi F, Sacerdote P, Solaro C, Zaffaroni M, Cavarretta R, Moiola L, Bucello S, Radaelli M, Pilato V, Rodegher M, Cursi M, Franchi S, Martinelli V, Nemni R, Comi G, Martino G (2008). "A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis". Multiple Sclerosis. 14 (8): 1076-83. doi:10.1177/1352458508095828. PMID 18728058.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Albrecht P, Fröhlich R, Hartung HP, Kieseier BC, Methner A (2007). "Optical coherence tomography measures axonal loss in multiple sclerosis independently of optic neuritis". J Neurol. Online (11): 1595. doi:10.1007/s00415-007-0538-3. PMID 17987252.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Gordon-Lipkin E, Chodkowski B, Reich DS; et al. (oktober 2007). "Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis". Neurology. 69 (16): 1603-09. doi:10.1212/01.wnl.0000295995.46586.ae. PMID 17938370. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Quintana FJ, Farez MF, Viglietta V, Iglesias AH, Merbl Y, Izquierdo G, Lucas M, Basso AS, Khoury SJ, Lucchinetti CF, Cohen IR, Weiner HL. (december 2008). "Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis". Proceeding of the National Academy of Sciences. 105 (48): 18889-94. doi:10.1073/pnas.0806310105. PMC 2596207. PMID 19028871.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Thangarajh M, Gomez-Rial J, Hedström AK; et al. (august 2008). "Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis". Mult. Scler. 14 (9): 1208. doi:10.1177/1352458508095729. PMID 18755821. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Zamboni, P; Galeotti, R; Menegatti, E; Malagoni, AM; Tacconi, G; Dall’Ara, S; Bartolomei, I; Salvi, F (2009). "Chronic Cerebrospinal venous insufficiency in patients with multiple sclerosis". Journal of Neurology, Neurosurgery and Psychiatry. BMJ Publishing Group. 80 (4): 392-399. doi:10.1136/jnnp.2008.157164. ISSN 1468-330X. Hentet 21. december 2009.

genzyme.com

"Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN". Genzyme. 2007-02-01. Hentet 2007-09-02.

msforumonline.net

Christensen T (juni 2007). "Human herpesviruses in MS" (PDF). Int MS J. 14 (2): 41-7. PMID 17686342.{{cite journal}}: CS1-vedligeholdelse: url-status (link)
Christensen T (maj 2006). "The role of EBV in MS pathogenesis" (PDF). Int MS J. 13 (2): 52-7. PMID 16635422.{{cite journal}}: CS1-vedligeholdelse: url-status (link)

msrc.co.uk

MS Resource Centre http://www.msrc.co.uk/index.cfm?CFID=2797780&CFTOKEN=19383080 Arkiveret 12. februar 2010 hos Wayback Machine

mxga-mstrial.co.uk

United Kingdom early Mitoxantrone Copaxone trial. Arkiveret 1. juni 2015 hos Wayback Machine Onyx Healthcare (2006-01-01). Hentet 2007-09-02.

nejm.org

content.nejm.org

Kleinschmidt-DeMasters BK, Tyler KL (2005). "Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis". N Engl J Med. 353 (4): 369-74. doi:10.1056/NEJMoa051782. PMID 15947079. Arkiveret fra originalen 1. december 2009. Hentet 6. februar 2010.
Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D (2005). "Progressive multifocal leukoencephalopathy in a patient treated with natalizumab". N Engl J Med. 353 (4): 375-81. doi:10.1056/NEJMoa051847. PMID 15947078. Arkiveret fra originalen 1. december 2009. Hentet 6. februar 2010.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)

neurology.org

Yao SY, Stratton CW, Mitchell WM, Sriram S (maj 2001). "CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens". Neurology. 56 (9): 1168-76. PMID 11342681.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Gronseth GS, Ashman EJ (maj 2000). "Practice parameter: the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology". Neurology. 54 (9): 1720-5. PMID 10802774.

neurologyreviews.com

"Some MS Patients have "Dramatic" Responses to Plasma Exchange". Neurology Reviews.com. marts 2000. Arkiveret fra originalen 7. august 2009. Hentet 2009-07-10.

nih.gov

pubmed.ncbi.nlm.nih.gov

Compston A, Coles A (oktober 2008). "Multiple sclerosis". Lancet. 372 (9648): 1502-17. doi:10.1016/S0140-6736(08)61620-7. PMID 18970977.
Rosati G (april 2001). "The prevalence of multiple sclerosis in the world: an update". Neurol. Sci. 22 (2): 117-39. doi:10.1007/s100720170011. PMID 11603614.
Compston A, Coles A (april 2002). "Multiple sclerosis". Lancet. 359 (9313): 1221-31. doi:10.1016/S0140-6736(02)08220-X. PMID 11955556.
Ascherio A, Munger KL (april 2007). "Environmental risk factors for multiple sclerosis. Part I: the role of infection". Ann. Neurol. 61 (4): 288-99. doi:10.1002/ana.21117. PMID 17444504.
Lublin FD, Reingold SC (april 1996). "Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis". Neurology. 46 (4): 907-11. PMID 8780061.
Weinshenker BG (1994). "Natural history of multiple sclerosis". Ann. Neurol. 36 (Suppl): S6-11. doi:10.1002/ana.410360704. PMID 8017890.
Petzold, Axel; Fraser, Clare L.; Abegg, Mathias (2022). "Diagnosis and classification of optic neuritis". The Lancet Neurology (engelsk). 21 (12). doi:10.1016/S1474-4422(22)00200-9. PMID 36179757.
Kurtzke JF (1983). "Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)". Neurology. 33 (11): 1444-52. PMID 6685237.
Tataru N, Vidal C, Decavel P, Berger E, Rumbach L (2006). "Limited impact of the summer heat wave in France (2003) on hospital admissions and relapses for multiple sclerosis". Neuroepidemiology. 27 (1): 28-32. doi:10.1159/000094233. PMID 16804331.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Heesen C, Mohr DC, Huitinga I; et al. (marts 2007). "Stress regulation in multiple sclerosis: current issues and concepts". Mult. Scler. 13 (2): 143-8. doi:10.1177/1352458506070772. PMID 17439878. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Martinelli V (2000). "Trauma, stress and multiple sclerosis". Neurol. Sci. 21 (4 Suppl 2): S849-52. doi:10.1007/s100720070024. PMID 11205361. Arkiveret fra originalen 1. november 2013. Hentet 6. februar 2010.
Dyment DA, Ebers GC, Sadovnick AD (februar 2004). "Genetics of multiple sclerosis". Lancet Neurol. 3 (92): 104-10. doi:10.1016/S1474-4422(03)00663-X. PMID 14747002.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Marrie RA (december 2004). "Environmental risk factors in multiple sclerosis aetiology". Lancet Neurol. 3 (12): 709-18. doi:10.1016/S1474-4422(04)00933-0. PMID 15556803.
Ascherio A, Munger KL (juni 2007). "Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors". Ann. Neurol. 61 (6): 504-13. doi:10.1002/ana.21141. PMID 17492755.
Spitsin S, Koprowski H (2008). "Role of uric acid in multiple sclerosis". Curr. Top. Microbiol. Immunol. 318: 325-42. doi:10.1007/978-3-540-73677-6_13. PMID 18219824.
Kurtzke JF (oktober 1993). "Epidemiologic evidence for multiple sclerosis as an infection". Clin. Microbiol. Rev. 6 (4): 382-427. PMC 358295. PMID 8269393. Arkiveret fra originalen 5. december 2012. Hentet 6. februar 2010.
Gilden DH (marts 2005). "Infectious causes of multiple sclerosis". Lancet Neurol. 4 (3): 195-202. PMID 15721830.
Christensen T (juni 2007). "Human herpesviruses in MS" (PDF). Int MS J. 14 (2): 41-7. PMID 17686342.{{cite journal}}: CS1-vedligeholdelse: url-status (link)
Johnston JB, Silva C, Holden J, Warren KG, Clark AW, Power C (oktober 2001). "Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases". Ann. Neurol. 50 (4): 434-42. doi:10.1002/ana.1131. PMID 11601494.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Christensen T (maj 2006). "The role of EBV in MS pathogenesis" (PDF). Int MS J. 13 (2): 52-7. PMID 16635422.{{cite journal}}: CS1-vedligeholdelse: url-status (link)
Yao SY, Stratton CW, Mitchell WM, Sriram S (maj 2001). "CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens". Neurology. 56 (9): 1168-76. PMID 11342681.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Chari DM (2007). "Remyelination in multiple sclerosis". Int. Rev. Neurobiol. 79: 589-620. doi:10.1016/S0074-7742(07)79026-8. PMID 17531860.
Pittock SJ, Lucchinetti CF (marts 2007). "The pathology of MS: new insights and potential clinical applications". Neurologist. 13 (2): 45-56. doi:10.1097/01.nrl.0000253065.31662.37. PMID 17351524.
Ho PP, Kanter JL, Johnson AM; et al. (juni 2012). "Identification of naturally occurring fatty acids of the myelin sheath that resolve neuroinflammation". Sci Transl Med. 4 (137): 137ra73. doi:10.1126/scitranslmed.3003831. PMID 22674551. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Wucherpfennig KW, Strominger JL (marts 1995). "Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein". Cell. 80 (5): 695-705. PMID 7534214.
Iglesias A, Bauer J, Litzenburger T, Schubart A, Linington C (november 2001). "T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis". Glia. 36 (2): 220-34. doi:10.1002/glia.1111. PMID 11596130.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Trojano M, Paolicelli D (november 2001). "The differential diagnosis of multiple sclerosis: classification and clinical features of relapsing and progressive neurological syndromes". Neurol. Sci. 22 (Suppl 2): s.98-102. doi:10.1007/s100720100044. PMID 11794488.
Poser CM, Brinar VV (juni 2004). "Diagnostic criteria for multiple sclerosis: an historical review". Clin Neurol Neurosurg. 106 (3): 147-58. doi:10.1016/j.clineuro.2004.02.004. PMID 15177763.
McDonald WI, Compston A, Edan G; et al. (juli 2001). "Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis". Ann. Neurol. 50 (1): 121-7. doi:10.1002/ana.1032. PMID 11456302. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Polman CH, Reingold SC, Edan G; et al. (december 2005). "Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"". Ann. Neurol. 58 (6): 840-6. doi:10.1002/ana.20703. PMID 16283615. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Rashid W, Miller DH (februar 2008). "Recent advances in neuroimaging of multiple sclerosis". Semin Neurol. 28 (1): 46-55. doi:10.1055/s-2007-1019127. PMID 18256986.
Link H, Huang YM (november 2006). "Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness". J. Neuroimmunol. 180 (1-2): 17-28. doi:10.1016/j.jneuroim.2006.07.006. PMID 16945427.
Gronseth GS, Ashman EJ (maj 2000). "Practice parameter: the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology". Neurology. 54 (9): 1720-5. PMID 10802774.
Pittock SJ, Rodriguez M (2008). "Benign multiple sclerosis: a distinct clinical entity with therapeutic implications". Curr. Top. Microbiol. Immunol. 318: 1-17. doi:10.1007/978-3-540-73677-6_1. PMID 18219812.
Miller D, Barkhof F, Montalban X, Thompson A, Filippi M (maj 2005). "Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis". Lancet Neurol. 4 (5): 281-8. doi:10.1016/S1474-4422(05)70071-5. PMID 15847841.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Rovaris M, Confavreux C, Furlan R, Kappos L, Comi G, Filippi M (april 2006). "Secondary progressive multiple sclerosis: current knowledge and future challenges". Lancet Neurol. 5 (4): 343-54. doi:10.1016/S1474-4422(06)70410-0. PMID 16545751.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Miller DH, Leary SM (oktober 2007). "Primary-progressive multiple sclerosis". Lancet Neurol. 6 (10): 903-12. doi:10.1016/S1474-4422(07)70243-0. PMID 17884680.
De Seze J (januar 2006). "Borderlines types of multiple sclerosis". Rev. Neurol. (Paris) (fransk). 162 (1): 137-43. PMID 16446632.
O'Riordan JI (juni 1997). "Central nervous system white matter diseases other than multiple sclerosis". Curr. Opin. Neurol. 10 (3): 211-4. PMID 9229127.
Brusaferri F, Candelise L (2000). "Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials". J. Neurol. 247 (6): 435-42. doi:10.1007/s004150070172. PMID 10929272.
Dovio A, Perazzolo L, Osella G; et al. (2004). "Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis". J. Clin. Endocrinol. Metab. 89 (10): 4923-8. doi:10.1210/jc.2004-0164. PMID 15472186. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Uttner I, Müller S, Zinser C; et al. (2005). "Reversible impaired memory induced by pulsed methylprednisolone in patients with MS". Neurology. 64 (11): 1971-3. doi:10.1212/01.WNL.0000163804.94163.91. PMID 15955958. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Jacobs LD, Beck RW, Simon JH; et al. (2000). "Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group". N Engl J Med. 343 (13): 898-904. doi:10.1056/NEJM200009283431301. PMID 11006365. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Comi G, Filippi M, Barkhof F; et al. (2001). "Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study". Lancet. 357 (9268): 1576-82. doi:10.1016/s0140-6736(00)04725-5. PMID 11377645. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Kappos L, Freedman MS, Polman CH; et al. (2007). "Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study". Lancet. 370 (9585): 389-97. doi:10.1016/S0140-6736(07)61194-5. PMID 17679016. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Ruggieri M, Avolio C, Livrea P, Trojano M (2007). "Glatiramer acetate in multiple sclerosis: a review". CNS Drug Rev. 13 (2): 178-91. doi:10.1111/j.1527-3458.2007.00010.x. PMID 17627671.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Munari L, Lovati R, Boiko A (2004). "Therapy with glatiramer acetate for multiple sclerosis". Cochrane Database Syst Rev (1): CD004678. doi:10.1002/14651858.CD004678. PMID 14974077.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Rice GP, Incorvaia B, Munari L; et al. (2001). "Interferon in relapsing-remitting multiple sclerosis". Cochrane Database Syst Rev (4): CD002002. doi:10.1002/14651858.CD002002. PMID 11687131. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Martinelli Boneschi F, Rovaris M, Capra R, Comi G (2005). "Mitoxantrone for multiple sclerosis". Cochrane Database Syst Rev (4): CD002127. doi:10.1002/14651858.CD002127.pub2. PMID 16235298.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Johnson KP (2007). "Control of multiple sclerosis relapses with immunomodulating agents". J. Neurol. Sci. 256 (Suppl 1): S23-8. doi:10.1016/j.jns.2007.01.060. PMID 17350652.
Gonsette RE (2007). "Compared benefit of approved and experimental immunosuppressive therapeutic approaches in multiple sclerosis". Expert opinion on pharmacotherapy. 8 (8): 1103-16. doi:10.1517/14656566.8.8.1103. PMID 17516874.
Murray TJ (2006). "The cardiac effects of mitoxantrone: do the benefits in multiple sclerosis outweigh the risks?". Expert opinion on drug safety. 5 (2): 265-74. doi:10.1517/14740338.5.2.265. PMID 16503747.
Leary SM, Thompson AJ (2005). "Primary progressive multiple sclerosis: current and future treatment options". CNS drugs. 19 (5): 369-76. doi:10.2165/00023210-200519050-00001. PMID 15907149.
Sládková T, Kostolanský F (2006). "The role of cytokines in the immune response to influenza A virus infection". Acta Virol. 50 (3): 151-62. PMID 17131933.
Fox EJ (2006). "Management of worsening multiple sclerosis with mitoxantrone: a review". Clinical therapeutics. 28 (4): 461-74. doi:10.1016/j.clinthera.2006.04.013. PMID 16750460.
Kleinschmidt-DeMasters BK, Tyler KL (2005). "Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis". N Engl J Med. 353 (4): 369-74. doi:10.1056/NEJMoa051782. PMID 15947079. Arkiveret fra originalen 1. december 2009. Hentet 6. februar 2010.
Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D (2005). "Progressive multifocal leukoencephalopathy in a patient treated with natalizumab". N Engl J Med. 353 (4): 375-81. doi:10.1056/NEJMoa051847. PMID 15947078. Arkiveret fra originalen 1. december 2009. Hentet 6. februar 2010.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Farinotti M, Simi S, Di Pietrantonj C; et al. (2007). "Dietary interventions for multiple sclerosis". Cochrane database of systematic reviews (Online) (1): CD004192. doi:10.1002/14651858.CD004192.pub2. PMID 17253500. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Chong MS, Wolff K, Wise K, Tanton C, Winstock A, Silber E (2006). "Cannabis use in patients with multiple sclerosis". Mult. Scler. 12 (5): 646-51. doi:10.1177/1352458506070947. PMID 17086912.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Zajicek JP, Sanders HP, Wright DE, Vickery PJ, Ingram WM, Reilly SM, Nunn AJ, Teare LJ, Fox PJ, Thompson AJ (2005). "Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up". J. Neurol. Neurosurg. Psychiatr. 76 (12): 1664-9. doi:10.1136/jnnp.2005.070136. PMC 1739436. PMID 16291891.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Bennett M, Heard R (2004). "Hyperbaric oxygen therapy for multiple sclerosis". Cochrane database of systematic reviews (Online) (1): CD003057. doi:10.1002/14651858.CD003057.pub2. PMID 14974004.
Oken BS, Kishiyama S, Zajdel D; et al. (2004). "Randomized controlled trial of yoga and exercise in multiple sclerosis". Neurology. 62 (11): 2058-64. PMID 15184614. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Phadke JG (maj 1987). "Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland". J. Neurol. Neurosurg. Psychiatr. 50 (5): 523-31. doi:10.1136/jnnp.50.5.523. PMC 1031962. PMID 3495637.
Myhr KM, Riise T, Vedeler C; et al. (februar 2001). "Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension". Mult. Scler. 7 (1): 59-65. PMID 11321195. Arkiveret fra originalen 21. februar 2021. Hentet 6. februar 2010. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Alonso A, Hernán MA (juli 2008). "Temporal trends in the incidence of multiple sclerosis: a systematic review". Neurology. 71 (2): 129-35. doi:10.1212/01.wnl.0000316802.35974.34. PMID 18606967.
Kulie T, Groff A, Redmer J, Hounshell J, Schrager S (2009). "Vitamin D: an evidence-based review". J Am Board Fam Med. 22 (6): 698-706. doi:10.3122/jabfm.2009.06.090037. PMID 19897699.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Compston A (oktober 1988). "The 150th anniversary of the first depiction of the lesions of multiple sclerosis". J. Neurol. Neurosurg. Psychiatr. 51 (10): 1249-52. doi:10.1136/jnnp.51.10.1249. PMC 1032909. PMID 3066846.
Medaer R (september 1979). "Does the history of multiple sclerosis go back as far as the 14th century?". Acta Neurol. Scand. 60 (3): 189-92. doi:10.1111/j.1600-0447.1979.tb08970.x. PMID 390966.
Holmøy T (2006). "A Norse contribution to the history of neurological diseases". Eur. Neurol. 55 (1): 57-8. doi:10.1159/000091431. PMID 16479124.
Pearce JM (2005). "Historical descriptions of multiple sclerosis". Eur. Neurol. 54 (1): 49-53. doi:10.1159/000087387. PMID 16103678.
The CAMMS223 Trial Investigators (2008). "Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis". N Engl J Med. 359 (17): 1786-1801. doi:10.1056/NEJMoa0802670. PMID 18946064.
Polman C, Barkhof F, Sandberg-Wollheim M, Linde A, Nordle O, Nederman T (2005). "Treatment with laquinimod reduces development of active MRI lesions in relapsing MS". Neurology. 64 (6): 987-91. doi:10.1212/01.WNL.0000154520.48391.69. PMID 15781813.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Darlington CL (2005). "Technology evaluation: NeuroVax, Immune Response Corp". Curr. Opin. Mol. Ther. 7 (6): 598-603. PMID 16370383.
Agrawal YP (2005). "Low dose naltrexone therapy in multiple sclerosis". Med. Hypotheses. 64 (4): 721-4. doi:10.1016/j.mehy.2004.09.024. PMID 15694688.
Gironi M, Martinelli-Boneschi F, Sacerdote P, Solaro C, Zaffaroni M, Cavarretta R, Moiola L, Bucello S, Radaelli M, Pilato V, Rodegher M, Cursi M, Franchi S, Martinelli V, Nemni R, Comi G, Martino G (2008). "A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis". Multiple Sclerosis. 14 (8): 1076-83. doi:10.1177/1352458508095828. PMID 18728058.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Albrecht P, Fröhlich R, Hartung HP, Kieseier BC, Methner A (2007). "Optical coherence tomography measures axonal loss in multiple sclerosis independently of optic neuritis". J Neurol. Online (11): 1595. doi:10.1007/s00415-007-0538-3. PMID 17987252.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Gordon-Lipkin E, Chodkowski B, Reich DS; et al. (oktober 2007). "Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis". Neurology. 69 (16): 1603-09. doi:10.1212/01.wnl.0000295995.46586.ae. PMID 17938370. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
Quintana FJ, Farez MF, Viglietta V, Iglesias AH, Merbl Y, Izquierdo G, Lucas M, Basso AS, Khoury SJ, Lucchinetti CF, Cohen IR, Weiner HL. (december 2008). "Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis". Proceeding of the National Academy of Sciences. 105 (48): 18889-94. doi:10.1073/pnas.0806310105. PMC 2596207. PMID 19028871.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Thangarajh M, Gomez-Rial J, Hedström AK; et al. (august 2008). "Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis". Mult. Scler. 14 (9): 1208. doi:10.1177/1352458508095729. PMID 18755821. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)

ncbi.nlm.nih.gov

Kurtzke JF (oktober 1993). "Epidemiologic evidence for multiple sclerosis as an infection". Clin. Microbiol. Rev. 6 (4): 382-427. PMC 358295. PMID 8269393. Arkiveret fra originalen 5. december 2012. Hentet 6. februar 2010.
Zajicek JP, Sanders HP, Wright DE, Vickery PJ, Ingram WM, Reilly SM, Nunn AJ, Teare LJ, Fox PJ, Thompson AJ (2005). "Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up". J. Neurol. Neurosurg. Psychiatr. 76 (12): 1664-9. doi:10.1136/jnnp.2005.070136. PMC 1739436. PMID 16291891.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Phadke JG (maj 1987). "Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland". J. Neurol. Neurosurg. Psychiatr. 50 (5): 523-31. doi:10.1136/jnnp.50.5.523. PMC 1031962. PMID 3495637.
Compston A (oktober 1988). "The 150th anniversary of the first depiction of the lesions of multiple sclerosis". J. Neurol. Neurosurg. Psychiatr. 51 (10): 1249-52. doi:10.1136/jnnp.51.10.1249. PMC 1032909. PMID 3066846.
Quintana FJ, Farez MF, Viglietta V, Iglesias AH, Merbl Y, Izquierdo G, Lucas M, Basso AS, Khoury SJ, Lucchinetti CF, Cohen IR, Weiner HL. (december 2008). "Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis". Proceeding of the National Academy of Sciences. 105 (48): 18889-94. doi:10.1073/pnas.0806310105. PMC 2596207. PMID 19028871.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)

nlm.nih.gov

Methylprednisolone Oral. US National Library of Medicine (Medline) (2003-04-01). Hentet d. 1. september 2007.
Methylprednisolone Sodium Succinate Injection. US National Library of Medicine (Medline) (2003-04-01). Hentet d. 1. september 2007.

pdl.com

"Daclizumab". PDL Biopharma. 2006-01-01. Arkiveret fra originalen 15. september 2007. Hentet 2007-09-02.

pnas.org

Quintana FJ, Farez MF, Viglietta V, Iglesias AH, Merbl Y, Izquierdo G, Lucas M, Basso AS, Khoury SJ, Lucchinetti CF, Cohen IR, Weiner HL. (december 2008). "Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis". Proceeding of the National Academy of Sciences. 105 (48): 18889-94. doi:10.1073/pnas.0806310105. PMC 2596207. PMID 19028871.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)

primetherapeutics.com

Primetherapeutics – serious liver damage per FDA – Primetherapeutics Arkiveret 2. oktober 2009 hos Wayback Machine

sagepub.com

msj.sagepub.com

Myhr KM, Riise T, Vedeler C; et al. (februar 2001). "Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension". Mult. Scler. 7 (1): 59-65. PMID 11321195. Arkiveret fra originalen 21. februar 2021. Hentet 6. februar 2010. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)

springer-ny.com

link.springer-ny.com

Martinelli V (2000). "Trauma, stress and multiple sclerosis". Neurol. Sci. 21 (4 Suppl 2): S849-52. doi:10.1007/s100720070024. PMID 11205361. Arkiveret fra originalen 1. november 2013. Hentet 6. februar 2010.
Trojano M, Paolicelli D (november 2001). "The differential diagnosis of multiple sclerosis: classification and clinical features of relapsing and progressive neurological syndromes". Neurol. Sci. 22 (Suppl 2): s.98-102. doi:10.1007/s100720100044. PMID 11794488.

ucl.ac.uk

discovery.ucl.ac.uk

Petzold, Axel; Fraser, Clare L.; Abegg, Mathias (2022). "Diagnosis and classification of optic neuritis". The Lancet Neurology (engelsk). 21 (12). doi:10.1016/S1474-4422(22)00200-9. PMID 36179757.

videnskab.dk

Overraskende fund: Sklerose-gener kan have været en fordel for vores forfædre. Videnskab.dk 2024

web.archive.org

Martinelli V (2000). "Trauma, stress and multiple sclerosis". Neurol. Sci. 21 (4 Suppl 2): S849-52. doi:10.1007/s100720070024. PMID 11205361. Arkiveret fra originalen 1. november 2013. Hentet 6. februar 2010.
"Some MS Patients have "Dramatic" Responses to Plasma Exchange". Neurology Reviews.com. marts 2000. Arkiveret fra originalen 7. august 2009. Hentet 2009-07-10.
Natalizumab reduces MS severity – http://www.abstracts2view.com/aan2008chicago/view.php?nu=AAN08L_P04.169 Arkiveret 7. juli 2011 hos Wayback Machine
Primetherapeutics – serious liver damage per FDA – Primetherapeutics Arkiveret 2. oktober 2009 hos Wayback Machine
Kleinschmidt-DeMasters BK, Tyler KL (2005). "Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis". N Engl J Med. 353 (4): 369-74. doi:10.1056/NEJMoa051782. PMID 15947079. Arkiveret fra originalen 1. december 2009. Hentet 6. februar 2010.
Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D (2005). "Progressive multifocal leukoencephalopathy in a patient treated with natalizumab". N Engl J Med. 353 (4): 375-81. doi:10.1056/NEJMoa051847. PMID 15947078. Arkiveret fra originalen 1. december 2009. Hentet 6. februar 2010.{{cite journal}}: CS1-vedligeholdelse: Flere navne: authors list (link)
Myhr KM, Riise T, Vedeler C; et al. (februar 2001). "Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension". Mult. Scler. 7 (1): 59-65. PMID 11321195. Arkiveret fra originalen 21. februar 2021. Hentet 6. februar 2010. {{cite journal}}: Eksplicit brug af et al. i: |author= (hjælp)CS1-vedligeholdelse: Flere navne: authors list (link)
United Kingdom early Mitoxantrone Copaxone trial. Arkiveret 1. juni 2015 hos Wayback Machine Onyx Healthcare (2006-01-01). Hentet 2007-09-02.
"Daclizumab". PDL Biopharma. 2006-01-01. Arkiveret fra originalen 15. september 2007. Hentet 2007-09-02.
MS Resource Centre http://www.msrc.co.uk/index.cfm?CFID=2797780&CFTOKEN=19383080 Arkiveret 12. februar 2010 hos Wayback Machine

worldcat.org

Zamboni, P; Galeotti, R; Menegatti, E; Malagoni, AM; Tacconi, G; Dall’Ara, S; Bartolomei, I; Salvi, F (2009). "Chronic Cerebrospinal venous insufficiency in patients with multiple sclerosis". Journal of Neurology, Neurosurgery and Psychiatry. BMJ Publishing Group. 80 (4): 392-399. doi:10.1136/jnnp.2008.157164. ISSN 1468-330X. Hentet 21. december 2009.

wsj.com

blogs.wsj.com

"Brain Infections Return for Multiple Sclerosis Drug Tysabri". 2008-08-01. Hentet 2008-08-01.